Archive by category | European Society of Human Reproduction & Embryology

ESHRE: To screen or not to screen?

I went to a fascinating session on pre-implantation genetic screening (PGS) this morning. That’s where a cell is taken from the early embryo during IVF, and screened for chromosomal abnormalities before it is implanted into the mother.  Read more

ESHRE: Protecting fertility in cancer patients

Just heard some results that could mean good news for male cancer patients. Alon Carmely from Bar-Ilan University in Ramat Gan, Israel, says he’s hopeful that a drug that enhances the immune system could help protect men’s testes from the effects of chemotherapy.  Read more

ESHRE: Gossip from the US

I had dinner last night with among others Sean Tipton, press officer for ESHRE’s American rival, the American Society for Reproductive Medicine (ASRM). He’s here to persuade delegates to attend the ASRM’s own meeting, to be held in New Orleans in October.  Read more

ESHRE: Getting round Italy’s law

Looking at the research that’s being presented here, one of the first things to strike me is the number of papers from Italian teams trying to get round their country’s restrictions on the use of in vitro fertilisation (IVF).  Read more

ESHRE: All about stem cells

Hello! I’m Jo Marchant, Nature’s news editor, and I’m here in Prague for the 22nd annual meeting of ESHRE, the European Society of Human Reproduction and Embryology. It’s a huge and wide-ranging meeting — I’m told there are over 6000 delegates here, including infertility specialists, embryologists, geneticists, stem cell scientists and developmental biologists.  Read more